Herborium Group, Inc. engages in the research, development, licensing, and trade of botanical therapeutic products. The company is headquartered in Missouri City, Texas. The firm responds to both consumers and healthcare professionals demand for treatment and prevention of selected diseases and health concerns. Its flagship product, AcnEase is an herbal, oral treatment for patients with acne or rosacea. The company is engaged in the development of a series of the artificial intelligence (AI)-based content products related to dermatological and beauty space. AcnEase Skin Management System is a set of complementary all natural skin products which enhance the results of AcnEase. Its products include Natural Multi-tasking Acne Mask, Firming Collagen Peptide Serum, Accelerated Botanical Brightening Serum, Firming Collagen Peptide Serum, RETINOL RX, Mineral Sun Defense SPF 30, Vitamin C Antioxidant Serum and Glycolic Smoothing Serum.
HBRM stock price ended at $0 on 星期二, after rising NaN%
On the latest trading day Jan 20, 2026, the stock price of HBRM rose by NaN%, climbing from $0.00 to $0.00. During the session, the stock saw a volatility of NaN%, with prices oscillating between a daily low of $0.00 and a high of $0.00. Notably, trading volume dropped by 890.0K shares on the last day despite the price increase, which may signal a potential uptick in risk in the near term. A total of 900.0K shares were traded, equating to a market value of approximately --.